Clinical Research in Valvular Heart Disease during COVID: Adapting to a Dynamic and Multifaceted Pandemic

Event dates
Location

3:00 p.m. ET, 2:00 p.m. CT, 12:00 p.m. PT

Clinical Research in Valvular Heart Disease during COVID: Adapting to a Dynamic and Multifaceted Pandemic

The COVID pandemic has caused major disruptions in clinical care and clinical research, including early feasibility, pivotal, and post-approval trials for valvular heart disease (VHD). In this webinar, leaders from the STS/ACC TVT Registry—Vinod H. Thourani, MD, and John D. Carroll, MD—will talk with investigators, representatives from the Food and Drug Administration (FDA), and industry about the clinical research disruption and how to mitigate its negative impacts. They will discuss:

  • Balancing COVID safety with the consequences of delayed VHD treatment 
  • Disruptions in resources, personnel, scheduling, and finances
  • Developing strategies for regional variations in the COVID curve 
  • Advantages and limitations of telehealth for research efforts
  • Managing new patient enrollment and retention, as well as best COVID prevention and testing practices
  • Changes in regulatory, reimbursement, and ethical oversight of clinical trials


This episode is cosponsored by the American College of Cardiology.

Moderators
John Carroll_resized.jpg John D. Carroll, MD
University of Colorado
Aurora, CO
Vinod Thourani suit_ratio_150.jpg Vinod H. Thourani, MD
Piedmont Heart Institute
Atlanta, GA 

 

Panelists
Allocco Headshot_ratio_150.jpg Dominic J. Allocco, MD  
Boston Scientific
Maple Grove, MN
 
Andy Farb_ratio_150.jpg Andrew Farb, MD
Food and Drug Administration
Silver Spring, MD
Susheel Kodali_ratio_150.jpg Susheel K. Kodali, MD
NewYork-Presbyterian/Columbia University Medical Center
New York, NY
Michael Mack-2_ratio_150.jpg Michael J. Mack, MD
Baylor Scott & White Health
Plano, TX
Reisman, Mark_ratio_150.jpg Mark Reisman, MD
UW Medicine
Seattle, WA
Barathi_Sethuraman_ratio_150.jpg Barathi Sethuraman, PhD 
Abbott
Santa Clara, CA
Changfu Wu_ratio_150.jpg Changfu Wu, PhD
Food and Drug Administration
Silver Spring, MD
Bram Zuckerman_ratio_150.jpg Bram D. Zuckerman, MD
Food and Drug Administration
Silver Spring, MD